CTRI/2024/08/072465尚未招募Unknown
A prospective study to evaluate cisplatin induced sensorineural hearing loss amongst patients of head and neck carcinoma receiving chemo radiotherapy - NI
Sri Venkateshwara Institute of medical sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Head and neck squamous cell carcinomas Stage I – IVb (AJCC Staging 8th Edition) (14) (American joint Committee on Cancer) requiring definitive CRT/ Adjuvant CRT
- •2. Various sites of HNC including oral cavity, oropharynx nasopharynx & hypopharynx
- •3. Age : 18 years and above
- •4. Eastern Cooperative Oncology Group (ECOG)
- •Performance Status Scale (PSS) – 0-2
- •5. Patients who have given approval for informed written consent
排除标准
- •Patients with distant metastasis Stage IV C
- •ECOG PSS – 3 - 4
- •Previous RT to the head-and-neck region
- •Lack of a pre-radiation audiometry
- •Patients with Congenital/ acquired hearing loss
- •Pregnant and Lactating mothers
研究者
相似试验
已完成
不适用
A phase I dose escalation study of cisplatin, pemetrexed and radiotherapy for inoperable stage III non-small cell lung cancerung cancerCancerLung cancerISRCTN91946477Erasmus Medical Center (The Netherlands)39
尚未招募
2 期
ANTS Trial (Australian Neoadjuvant Therapy Study for Non-small Cell Lung Cancer)ACTRN12608000061336Austin Health100
已完成
2 期
A randomized phase II study comparing cisplatin + docetaxel with carboplatin + paclitaxel in patients with Stage III (N 2 positive) non-small-cell lung cancer who receive trimodality treatment consisting of chemoradiotherapy followed by surgery (OLCSG1601)previously untreated non-small-cell lung ccancer, stage III (N2 positive)JPRN-UMIN000024816Okayama Lung Cancer Study Group (OLCSG)80
已完成
2 期
Multicenter randomized phase II study of cisplatin+pemetrexed+bevacizmab followed by maintenance pemetrexied with or without bevacizmab in patients chemoterapy-naive advanced non-squamous non-small cell lung cancer with wild type EGFR(TORG1321)JPRN-UMIN000010681Thoracic Oncology Tesearch Group108
进行中（未招募）
1 期
A Phase II single-arm trial to evaluate cisplatin and gemcitabine chemotherapy in combination with sunitinib for first-line treatment of patients with advancd transitional carcinoma of the urothelium. - SUCCINCTEUCTR2007-007591-42-GBCardiff University63